Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF165 and VEGF121
被引:235
作者:
Whitaker, GB
论文数: 0引用数: 0
h-index: 0
机构:
Procter & Gamble Pharmacuet, Hlth Care Res Ctr, Dept Cardiovasc Res, Mason, OH 45040 USAProcter & Gamble Pharmacuet, Hlth Care Res Ctr, Dept Cardiovasc Res, Mason, OH 45040 USA
Whitaker, GB
[1
]
Limberg, BJ
论文数: 0引用数: 0
h-index: 0
机构:
Procter & Gamble Pharmacuet, Hlth Care Res Ctr, Dept Cardiovasc Res, Mason, OH 45040 USAProcter & Gamble Pharmacuet, Hlth Care Res Ctr, Dept Cardiovasc Res, Mason, OH 45040 USA
Limberg, BJ
[1
]
Rosenbaum, JS
论文数: 0引用数: 0
h-index: 0
机构:
Procter & Gamble Pharmacuet, Hlth Care Res Ctr, Dept Cardiovasc Res, Mason, OH 45040 USAProcter & Gamble Pharmacuet, Hlth Care Res Ctr, Dept Cardiovasc Res, Mason, OH 45040 USA
Rosenbaum, JS
[1
]
机构:
[1] Procter & Gamble Pharmacuet, Hlth Care Res Ctr, Dept Cardiovasc Res, Mason, OH 45040 USA
The two most abundant secreted isoforms of vascular endothelial growth factor A (VEGF(165) and VEGF(121)) are formed as a result of differential splicing of the VEGF-A gene. VEGF(165) and VEGF(121) share similar affinities at the isolated VEGF receptor (VEGFR)-2 but have been previously demonstrated to have differential ability to activate VEGFR-2-mediated effects on endothelial cells. Herein we investigate whether the recently described VEGF(165) isoform-specific receptor neuropilin-1 (Npn-1) is responsible for the difference in potency observed for these ligands, We demonstrate that although VEGFR-2 and Npn-1 form a complex, this complex does not result in an increase in VEGF(165) binding affinity. Therefore, the differential activity of VEGF(165) and VEGF(121) cannot be explained by a differential binding affinity for the complex. Using an antagonist that competes for VEGF(165) binding at the VEGFR-2(.)Npn-1 complex, we observe specific antagonism of VEGF(165)-meditated phosphorylation of VEGFR-2 without affecting the VEGF(121) response. These data indicate that the formation of the complex is responsible for the increased potency of VEGF(165) versus VEGF(121). Taken together, these data suggest a receptor-clustering role for Npn-1, as opposed to Npn-1 behaving as an affinity-converting subunit.